Diagnostic evaluation of the BD Affirm VPIII assay as a point-of-care test for the diagnosis of bacterial vaginosis, trichomoniasis and candidiasis

Int J STD AIDS. 2020 Mar;31(4):303-311. doi: 10.1177/0956462419895684. Epub 2020 Feb 12.

Authors

Fazana Dessai¹, Makandwe Nyirenda^{2

3}, Motshedisi Sebitloane⁴, Nathlee Abbai¹

Affiliations

¹ School of Clinical Medicine Laboratory, University of KwaZulu Natal, Durban, South Africa.
² South African Medical Research Council, Durban, South Africa.
³ School of Public Health and Nursing, University of KwaZulu Natal, Durban, South Africa.
⁴ Discipline of Obstetrics and Gynaecology, School of Clinical Medicine, University of KwaZulu Natal, Durban, South Africa.

PMID: 32050856
DOI: 10.1177/0956462419895684

No abstract available

Keywords: Affirm; Candida; South Africa; Trichomonas; Trichomonas vaginalis; antenatal; bacterial vaginosis; max; pregnant; prevalence.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Candida albicans / isolation & purification*
Candidiasis / diagnosis*
Candidiasis / epidemiology
Female
Humans
Point-of-Care Systems
Pregnancy
Prevalence
South Africa / epidemiology
Trichomonas / isolation & purification*
Trichomonas Infections / diagnosis*
Trichomonas Infections / epidemiology
Vaginosis, Bacterial / diagnosis*
Vaginosis, Bacterial / epidemiology